ASCO: No Benefit from Avastin in Glioblastoma

ASCO: No Benefit from Avastin in Glioblastoma. Patients with newly diagnosed glioblastoma lived no longer with the addition of bevacizumab (Avastin) to chemoradiation than they did without it, results of a large multicenter trial showed.

SOURCE: Gilbert MR, et al “RTOG 0825: Phase III double-blind, placebo-controlled trial evaluating bevacizumab in patiens with newly diagnosed glioblastoma” ASCO 2013; Abstract 1.

Comments are closed

Testimonials Patient Portal Schedule an Appointment

After an airplane crash in the mountains, I was rescued & airlifted to a trauma center with a broken back. Images were showing bone fragments pushing well into the spinal canal threatening paralysis of the lower half of my body which was not good news particularly for us newlyweds. Consulting with the trauma team, we compiled a short list of top neurosurgeons in Los Angeles area which included Dr. Jose Rodriguez.

When we contacted him, he assembled a surgical team and operated on me. I recovered quickly under Dr. Rodriguez' post operative care and physiotherapy. Within days, I started walking without any nerve damage and within a few months was swimming laps as I was doing before the injury. I am extremely grateful to Dr. Rodriguez and his outstanding team.

November 13, 2013

×